Clinical trial
Vaccine Therapy in Treating Patients With Head and Neck Cancer
NCT00404339 · Robert Ferris, Other · Completed
Key facts
| NCT number | NCT00404339 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Head and Neck Cancer |
| Official title | Adjuvant p53 Peptide Loaded DC-Based Therapy for Subjects With Squamous Cell Cancer of the Head and Neck (A Phase I Safety and Immunogenicity Trial) |
| Lead sponsor | Robert Ferris, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Procedure |
| Interventions | mutant p53 peptide pulsed dendritic cell vaccine, tetanus toxoid helper peptide, adjuvant therapy |
| Enrollment | 17 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2014 |
| First posted | Nov 28, 2006 |
| Last update posted | Apr 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: